You are adding an alert for:
Sustained anti-VEGF activity of aflibercept (EyleaTM) after storage in polycarbonate syringes used for intravitreal injection: a pathway to safety and efficiency in high volume clinics providing intravitreal therapy.
You will receive an email whenever this article is corrected, updated, or cited in the literature. You can manage this and all other alerts in My Account
The alert will be sent to: